Vilon
Immune bioregulator dipeptide
Immune-system dipeptide.
Half-life
~ hours
Mol. weight
~ 276.3 g/mol
Sequence
Lys-Glu (KE)
Discussions
0 threads
Overview
A dipeptide (Lys-Glu) — just two amino acids — in the Khavinson bioregulator tradition, studied for regulating gene expression in immune and connective tissues. As the shortest peptide in the bioregulator class, it represents the extreme end of the 'ultra-short peptides regulate transcription' concept, and members approach it with particular mechanistic skepticism.
Mechanism of action
Vilon is a dipeptide (Lys-Glu) studied in the Khavinson bioregulator framework for regulating gene expression in immune and connective tissues. The proposal that a two-amino-acid molecule can specifically modulate transcription is the extreme version of the bioregulator concept. Mechanistically, two residues rarely provide the structural complexity for specific receptor binding or defined transcription-factor interaction, which is why this is the thinnest-evidence tier in peptide science.
Researched benefits
- Studied for immune/connective tissue regulation
- Extreme short format (dipeptide)
- Tissue-regulation research concept
Considerations
- Two amino acids rarely allow specific binding — mechanistically skeptical
- Thinnest evidence tier in peptide science
- Human data limited; one research tradition
Key Academic Literature & Studies
Search more in PubMedPeer-reviewed citations and clinical trials evaluating Vilon in scientific literature.
Query PubMed for recent peer-reviewed preclinical and clinical publications on Vilon:
View Vilon index on PubMed (NCBI)